A mutational comparison of adult and adolescent and young adult (AYA) colon cancer
- PMID: 29194591
- PMCID: PMC5821537
- DOI: 10.1002/cncr.31136
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer
Abstract
Background: It is possible that the relative lack of progress in treatment outcomes among adolescent and young adult (AYA) patients with cancer is caused by a difference in disease biology compared with the corresponding diseases in younger and older individuals. There is evidence that colon cancer is more aggressive and has a poorer prognosis in AYA patients than in older adult patients.
Methods: To further understand the molecular basis for this difference, whole-exome sequencing was conducted on a cohort of 30 adult, 30 AYA, and 2 pediatric colon cancers.
Results: A statistically significant difference in mutational frequency was observed between AYA and adult samples in 43 genes, including ROBO1, MYC binding protein 2 (MYCBP2), breast cancer 2 (early onset) (BRCA2), MAP3K3, MCPH1, RASGRP3, PTCH1, RAD9B, CTNND1, ATM, NF1; KIT, PTEN, and FBXW7. Many of these mutations were nonsynonymous, missense, stop-gain, or frameshift mutations that were damaging. Next, RNA sequencing was performed on a subset of the samples to confirm the mutations identified by exome sequencing. This confirmation study verified the presence of a significantly greater frequency of damaging mutations in AYA compared with adult colon cancers for 5 of the 43 genes (MYCBP2, BRCA2, PHLPP1, TOPORS, and ATR).
Conclusions: The current results provide the rationale for a more comprehensive study with a larger sample set and experimental validation of the functional impact of the identified variants along with their contribution to the biologic and clinical characteristics of AYA colon cancer. Cancer 2018;124:1070-82. © 2017 American Cancer Society.
Keywords: RNA sequencing (RNASeq); adolescent and young adult (AYA); colon cancer; exome sequencing; mutation.
© 2017 American Cancer Society.
Conflict of interest statement
Similar articles
-
Current status of AYA-generation breast cancer: trends worldwide and in Japan.Int J Clin Oncol. 2022 Jan;27(1):16-24. doi: 10.1007/s10147-021-02087-4. Epub 2021 Dec 18. Int J Clin Oncol. 2022. PMID: 34921319 Review.
-
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.Int J Cancer. 2019 Mar 1;144(5):1049-1060. doi: 10.1002/ijc.31791. Epub 2018 Nov 21. Int J Cancer. 2019. PMID: 30178487
-
Whole-exome sequencing identified mutational profiles of high-grade colon adenomas.Oncotarget. 2017 Jan 24;8(4):6579-6588. doi: 10.18632/oncotarget.14172. Oncotarget. 2017. PMID: 28179590 Free PMC article.
-
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1. BMC Cancer. 2016. PMID: 26925973 Free PMC article.
-
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.Cancer. 2016 Apr 1;122(7):1017-28. doi: 10.1002/cncr.29871. Epub 2016 Feb 5. Cancer. 2016. PMID: 26849082 Free PMC article. Review.
Cited by
-
Association between different regional lymph node metastases of papillary thyroid carcinoma in adolescents and young adults.Oncol Lett. 2024 Mar 11;27(5):204. doi: 10.3892/ol.2024.14337. eCollection 2024 May. Oncol Lett. 2024. PMID: 38516681 Free PMC article.
-
Describing patterns of familial cancer risk in subfertile men using population pedigree data.Hum Reprod. 2024 Apr 3;39(4):822-833. doi: 10.1093/humrep/dead270. Hum Reprod. 2024. PMID: 38383051
-
Patient-Reported Outcomes of Accelerated Aging: A Novel Approach to Investigate Second Cancer Risk in Adolescent and Young Adult (18-39 Years) Cancer Survivors.Oncologist. 2024 Apr 4;29(4):e526-e534. doi: 10.1093/oncolo/oyad307. Oncologist. 2024. PMID: 37995309 Free PMC article.
-
Colorectal cancer in adolescent and young adults: epidemiology in Japan and narrative review.J Gastrointest Oncol. 2023 Aug 31;14(4):1856-1868. doi: 10.21037/jgo-23-98. Epub 2023 Jul 19. J Gastrointest Oncol. 2023. PMID: 37720434 Free PMC article. Review.
-
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.JCO Precis Oncol. 2023 Aug;7:e2200594. doi: 10.1200/PO.22.00594. JCO Precis Oncol. 2023. PMID: 37561981 Free PMC article.
References
-
- Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: Apr, 2013. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted in the SEER web site.
-
- Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288–298. - PubMed
-
- Liang JT, Huang KC, Cheng AL, et al. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surgery. 2003;90:205–214. - PubMed
-
- Liu B, Farrington SM, Petersen GM, et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med. 1995;1:348–352. - PubMed
-
- Kakar S, Aksoy S, Burgart LJ, et al. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Modern Path. 2004;17:696–700. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous